To the Editor: Joura et al. (Feb. 19 issue)1 report that the 9-valent vaccine against human papillomavirus (9vHPV) had an efficacy of 96.7% to prevent high-grade cervical, vulvar, or vaginal dysplasia related to HPV types 31, 33, 45, 52, and 58 in women. Men who are positive for the human immunodeficiency virus and who have sex with men (HIV+MSM) have a… (More)
Figures and Tables
Sorry, we couldn't extract any figures or tables for this paper.